Marion Harris
Monash Medical Centre
51 Papers
108 Citations
Marion Harris is an academic researcher from Monash Medical Centre. The author has contributed to research in topics: Medicine & Gemcitabine. The author has an hindex of 16, co-authored 40 publications. Previous affiliations of Marion Harris include Monash University, Clayton campus & VU University Medical Center.
Chat about Author
Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff,Thomas J. Ervin,Francis P. Arena,E. Gabriela Chiorean,Jeffrey R. Infante,Malcolm J. Moore,Thomas E. Seay,Sergei Tjulandin,Wen Wee Ma,Mansoor N. Saleh,Marion Harris,Michele Reni,Scot Dowden,Daniel A. Laheru,Nathan Bahary,Ramesh K. Ramanathan,Josep Tabernero,Manuel Hidalgo,David Goldstein,Eric Van Cutsem,Xinyu Wei,Jose Iglesias,Markus F. Renschler +22 more
TL;DR: In patients with metastatic pancreatic adenocarcinoma, nab-paclitaxel plus gemcitabine significantly improved overall survival, progression-free survival, and response rate, but rates of peripheral neuropathy and myelosuppression were increased.
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.
Jeanne Tie,Joshua T. Cohen,Kamel Lahouel,Serigne Lo,Yuxuan Wang,Suzanne Kosmider,Rachel Wong,Jeremy Shapiro,Margaret S. Lee,S. Harris,Adnan Khattak,Matthew Burge,Marion Harris,James Lynam,Louise M. Nott,Fiona Day,Teresa G. Hayes,Sue Anne McLachlan,Belinda Lee,Janine Ptak,Natalie Silliman,Lisa Dobbyn,Maria Popoli,Ralph H. Hruban,Anne Marie Lennon,Nickolas Papadopoulos,Kenneth W. Kinzler,Bert Vogelstein,Cristian Tomasetti,Peter Gibbs +29 more
TL;DR: A ctDNA-guided approach to the treatment of stage II colon cancer reduced adjuvant chemotherapy use without compromising recurrence-free survival.
309
Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study
Elizabeth Bancroft,Elizabeth Page,Elena Castro,Hans Lilja,Andrew J. Vickers,Daniel Sjöberg,Melissa Assel,Christopher S. Foster,Gillian Mitchell,Kate Drew,Lovise Maehle,Karol Axcrona,D. Gareth Evans,Barbara Bulman,Diana Eccles,Donna McBride,Christi J. van Asperen,Hans F. A. Vasen,Lambertus A. Kiemeney,Janneke Ringelberg,Cezary Cybulski,Dominika Wokołorczyk,Christina G. Selkirk,Peter J. Hulick,Anders Bojesen,Anne-Bine Skytte,Jimmy Lam,Louise Taylor,Rogier A. Oldenburg,Ruben Cremers,Gerald W. Verhaegh,Wendy A. G. van Zelst-Stams,Jan C. Oosterwijk,Ignacio Blanco,Mónica Salinas,Jackie Cook,Derek J. Rosario,Saundra S. Buys,Tom Conner,Margreet G. E. M. Ausems,Kai Ren Ong,Jonathan Hoffman,Susan M. Domchek,Jacquelyn Powers,Manuel R. Teixeira,Sofia Maia,William D. Foulkes,Nassim Taherian,Marielle W. G. Ruijs,Apollonia T.J.M. Helderman van den Enden,Louise Izatt,Rosemarie Davidson,Muriel A. Adank,Lisa Walker,Rita K. Schmutzler,Katherine M. Tucker,Judy Kirk,Shirley Hodgson,Marion Harris,Fiona Douglas,Geoffrey J. Lindeman,Janez Zgajnar,Marc Tischkowitz,Virginia E. Clowes,Rachel Susman,Teresa Ramón y Cajal,Nicholas Patcher,Nicholas Patcher,Neus Gadea,Allan D. Spigelman,Theo A. M. van Os,Annelie Liljegren,Lucy Side,Carole Brewer,Angela F. Brady,Alan Donaldson,Vigdis Stefansdottir,Eitan Friedman,Rakefet Chen-Shtoyerman,David J. Amor,Lucia Copakova,Julian Barwell,Veda N. Giri,Vedang Murthy,Nicola Nicolai,Soo Hwang Teo,Lynn Greenhalgh,Sara S. Strom,Alex Henderson,John S. McGrath,David J. Gallagher,Neil K. Aaronson,Audrey Ardern-Jones,Chris H. Bangma,David P. Dearnaley,Philandra Costello,Jorunn E. Eyfjord,Jeanette Rothwell,Alison Falconer,Henrik Grönberg,Freddie C. Hamdy,Oskar T. Johannsson,Vincent Khoo,Zsofia Kote-Jarai,Jan Lubinski,Ulrika Axcrona,J Melia,Joanne McKinley,A. Mitra,Clare Moynihan,Gad Rennert,Mohnish Suri,Penny Wilson,Emma Killick,Sue Moss,Rosalind A. Eeles +115 more
TL;DR: The IMPACT screening network is an international consortium of 62 centres in 20 countries evaluating the use of targeted PCa screening in men with BRCA1/2 mutations.
233
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
Elizabeth Page,Elizabeth Bancroft,Mark N. Brook,Melissa Assel,Mona Hassan Al Battat,Sarah Thomas,Natalie Taylor,Anthony Chamberlain,Jennifer Pope,Holly Ni Raghallaigh,D. Gareth Evans,Jeanette Rothwell,Lovise Maehle,Eli Marie Grindedal,Paul A. James,Paul A. James,Paul A. James,Lyon Mascarenhas,Joanne McKinley,Lucy Side,Tessy Thomas,Christi J. van Asperen,Hans F. A. Vasen,Lambertus A. Kiemeney,Janneke Ringelberg,Thomas Dyrso Jensen,Palle Jørn Sloth Osther,Brian T. Helfand,Elena Genova,Rogier A. Oldenburg,Cezary Cybulski,Dominika Wokołorczyk,Kai-ren Ong,Camilla Huber,Jimmy Lam,Louise Taylor,Mónica Salinas,Lídia Feliubadaló,Jan C. Oosterwijk,Wendy A. G. van Zelst-Stams,Jackie Cook,Derek J. Rosario,Susan M. Domchek,Jacquelyn Powers,Saundra S. Buys,Karen O’Toole,Margreet G. E. M. Ausems,Rita K. Schmutzler,Kerstin Rhiem,Louise Izatt,Vishakha Tripathi,Manuel R. Teixeira,Marta Cardoso,William D. Foulkes,William D. Foulkes,Armen Aprikian,Heleen van Randeraad,Rosemarie Davidson,Mark Longmuir,Marielle W. G. Ruijs,Apollonia T.J.M. Helderman van den Enden,Muriel A. Adank,Rachel Williams,Lesley Andrews,Declan G. Murphy,Declan G. Murphy,Dorothy Halliday,Lisa Walker,Annelie Liljegren,Stefan Carlsson,Ashraf Azzabi,Irene Jobson,Catherine Morton,Kylie Shackleton,Katie Snape,Helen Hanson,Marion Harris,Marc Tischkowitz,Amy E Taylor,Judy Kirk,Judy Kirk,Rachel Susman,Rakefet Chen-Shtoyerman,Allan D. Spigelman,Allan D. Spigelman,Nicholas Pachter,Nicholas Pachter,Munaza Ahmed,Teresa Ramón y Cajal,Janez Zgajnar,Carole Brewer,Carole Brewer,Neus Gadea,Angela F. Brady,Theo A. M. van Os,David J. Gallagher,Oskar T. Johannsson,Alan Donaldson,Julian Barwell,Nicola Nicolai,Eitan Friedman,Elias Obeid,Lynn Greenhalgh,Vedang Murthy,Lucia Copakova,Sibel Saya,John S. McGrath,John S. McGrath,Peter Cooke,Karina Rønlund,Kate Richardson,Alex Henderson,Soo Hwang Teo,Banu Arun,Karin Kast,Alexander Dias,Neil K. Aaronson,Audrey Ardern-Jones,Chris H. Bangma,Elena Castro,David P. Dearnaley,Diana Eccles,Diana Eccles,K. Tricker,Jorunn E. Eyfjord,Alison Falconer,Christopher S. Foster,Henrik Grönberg,Freddie C. Hamdy,Freddie C. Hamdy,Vigdis Stefansdottir,Vincent Khoo,Geoffrey J. Lindeman,Geoffrey J. Lindeman,Geoffrey J. Lindeman,Jan Lubinski,Karol Axcrona,Christos Mikropoulos,Anita Mitra,Clare Moynihan,Gadi Rennert,Mohnish Suri,Penny Wilson,Tim Dudderidge,Judith Offman,Zsofia Kote-Jarai,Andrew J. Vickers,Hans Lilja,Hans Lilja,Hans Lilja,Rosalind A. Eeles +150 more
TL;DR: After 3 yr of prostate-specific antigen (PSA) testing, it is demonstrated that after 3’yr of screening, more serious prostate cancers are detected in men with BRCA2 mutations than in those without these mutations.
209
Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer
Belinda Lee,Belinda Lee,Belinda Lee,Lara Lipton,Joshua D. Cohen,Jeanne Tie,Ammar A. Javed,Lu Li,David Goldstein,Matthew Burge,Prasad Cooray,Adnan Nagrial,Niall C. Tebbutt,Benjamin N. J. Thomson,Benjamin N. J. Thomson,Mehrdad Nikfarjam,Marion Harris,Andrew Haydon,B. Lawrence,D W M Tai,Koen Simons,A M Lennon,C L Wolfgang,Cristian Tomasetti,Cristian Tomasetti,Nick Papadopoulos,Kenneth W. Kinzler,Bert Vogelstein,Peter Gibbs +28 more
TL;DR: CTDNA analysis, pre- and/or post-surgery, is a promising prognostic marker and studies of ctDNA guided therapy are justified, including of treatment intensification strategies for patients with detectable ct DNA post-operatively who appear at very high risk of recurrence despite gemcitabine-based adjuvant therapy.
173